Incidence and therapy of cytomegalovirus disease after liver transplantation

Transplant Proc. 1993 Apr;25(2):1985-6.

Authors

M Wiens¹, B Lefèbre, G Blumhardt, C A Schmidt, R Lohmann, P Neuhaus

Affiliation

¹ Department of Surgery, Free University of Berlin, UKRV-W, Germany.

PMID: 8385829

No abstract available

MeSH terms

Acyclovir / therapeutic use
Cytomegalovirus Infections / epidemiology*
Cytomegalovirus Infections / prevention & control
Cytomegalovirus Infections / therapy*
Drug Therapy, Combination
Ganciclovir / therapeutic use
Humans
Immunization, Passive
Immunoglobulins
Immunoglobulins, Intravenous
Immunosuppressive Agents / therapeutic use
Incidence
Liver Transplantation* / immunology
Postoperative Complications / epidemiology*
Postoperative Complications / prevention & control
Postoperative Complications / therapy*
Retrospective Studies
Risk Factors

Substances

Immunoglobulins
Immunoglobulins, Intravenous
Immunosuppressive Agents
cytomegalovirus-specific hyperimmune globulin
Ganciclovir
Acyclovir